Ninety One North America Inc. Invests in Boston Scientific Corporation

The investment firm acquired over 77,000 shares of the medical device company in Q4 2025.

Apr. 18, 2026 at 12:06pm

A high-contrast, close-up image of intricate medical device components and machinery, conveying a sense of precision, innovation, and the complex technology behind Boston Scientific's products.Ninety One North America's investment in Boston Scientific reflects ongoing institutional confidence in the medical device company's growth and technological capabilities.Marlborough Today

Ninety One North America Inc. acquired a new position in Boston Scientific Corporation (NYSE:BSX) during the 4th quarter of 2025, purchasing 77,718 shares of the medical equipment provider's stock valued at approximately $7.41 million. Several other hedge funds and institutional investors also made moves related to Boston Scientific during the quarter.

Why it matters

Boston Scientific is a major player in the medical device industry, developing and manufacturing a wide range of products used in minimally invasive procedures. Ninety One North America's investment reflects confidence in the company's growth potential and market position.

The details

Ninety One North America Inc. added the new Boston Scientific position in Q4 2025. The investment firm acquired 77,718 shares of the medical equipment provider's stock. Several other hedge funds and institutional investors also made transactions involving Boston Scientific shares during the quarter, indicating ongoing investor interest in the company.

  • Ninety One North America Inc. acquired the new Boston Scientific position in the 4th quarter of 2025.

The players

Ninety One North America Inc.

An investment management firm that acquired a new position in Boston Scientific Corporation.

Boston Scientific Corporation

A global medical device company that develops, manufactures, and markets a broad portfolio of products used in less-invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

Ninety One North America's investment in Boston Scientific reflects ongoing institutional confidence in the medical device company's growth prospects and market leadership position.